Innovation in Obesity Pathways - Market Engagement Opportunity

NHS Kent and Medway ICB are preparing to bid for grant funding under the Obesity Pathway Innovation Programme (OPIP): Strand 3-Combined Access and Management for Healthy Ageing and Tackling Obesity, a national innovation competition jointly funded by the Department for Science, Innovation and Technology (DSIT) and Eli Lilly and Company Limited, with up to £85 million available across the UK. A single ICB cannot be awarded any more than £8 million in total. To inform our competition response, we are launching a mark...